pylori urease activates platelets through a lipoxygenase-mediated pathway, leading to ADP exocytosis and, therefore, platelet aggregation ( Wassermann et al., 2010). In this study we aimed to evaluate the participation of H. pylori urease in the acute inflammatory process promoted by CAL-101 molecular weight this bacterium. For that purpose we worked with a purified recombinant HPU (rHPU) produced in Escherichia coli. Our results showed that rHPU induces: (i) mouse paw edema; (ii) human neutrophil migration; (iii) protection of human neutrophils against apoptosis; (iv) production of

reactive oxygen species by neutrophils, and (v) induction of expression of lipoxygenase(s) in human neutrophils. H. pylori recombinant urease (rHPU) was produced by heterologous expression ( McGee et al., 1999) in E. coli SE5000 transformed with plasmid pHP8080, kindly provided by Dr. Harry T. Mobley, University of Michigan Medical School. rHPU was purified from bacterial extracts as previously described ( Wassermann et al., 2010). For the experiments, the purified protein was concentrated using Centriprep cartridges (30 kDa cut-off) to give a 0.5 mg protein/mL solution ( Suppl. Fig. 1) and dialyzed against 20 mM sodium phosphate,

pH 7.5, 1 mM EDTA, 5 mM 2-mercaptoethanol. The buffer from the last dialysis change was used as a negative control in all bioassays. Protein content of samples was determined by their absorbance at 280 nm, or by the APO866 purchase Coomassie

dye binding method (Bradford, 1976). Urease activity was measured colorimetrically by the alkaline nitroprussiate method (Weatherburn, 1967). For studies of urease inhibition, protein solutions were incubated overnight at 4 °C with 1 mM p-hydroxy-mercurybenzoate followed by extensive Tideglusib dialysis to remove excess of inhibitor (Follmer et al., 2001). Neutrophils were isolated from EDTA (0.5%)-treated peripheral venous blood of healthy human volunteers by Percoll gradient (Coelho et al., 2004) and suspended in RPMI medium (97% of viable cells, as assessed by trypan blue exclusion). Residual erythrocytes were removed by hypotonic lysis. Chemotaxis was assayed in 48-well microchemotaxis chambers (NeuroProbe, Gaithersburg, MD) using 5-μm polycarbonate filter (Coelho et al., 2004). Neutrophils (106 cells/mL in RPMI, 0.01% bovine serum albumin, BSA) were allowed to migrate toward formyl-methionyl-leucyl-phenylalanine (fMLP, 100 nM), rHPU (10 nM, 30 nM, 100 nM) or medium (random migration; 37 °C, 5% CO2). After 1 h, filters were removed, fixed, stained, and neutrophils that migrated through the membrane were counted under a light microscope on at least 5 randomly selected fields (Coelho et al., 2004). To evaluate the participation of 5-lipoxygenase products, cells were treated with AA861 (10 μM) for 15 min prior to stimulation with rHPU. Each treatment was assayed in triplicate. Results are expressed as mean ± S.E.M.